FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018792227> ?p ?o ?g. }

• W2018792227 endingPage "179" @default.
• W2018792227 startingPage "172" @default.
• W2018792227 abstract "Abstract Mitochondria are involved directly in cell survival and death. The assumption has been made that drugs that protect mitochondrial viability and prevent apoptotic cascade‐induced mitochondrial permeability transition pore (MPTp) opening will be cytoprotective. Rasagiline ( N ‐propargyl‐1 R ‐aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO) B inhibitor anti‐Parkinson drug. Unlike selegiline, it is not derived from amphetamine, and is not metabolized to neurotoxic L ‐methamphetamine derivative. In addition, it does not have sympathomimetic activity. Rasagiline is effective as monotherapy or adjunct to levodopa for patients with early and late Parkinson's disease (PD) and adverse events do not occur with greater frequency in subjects receiving rasagiline than in those on placebo. Phase III controlled studies indicate that it might have a disease‐modifying effect in PD that may be related to its neuroprotective activity. Its S isomer, TVP1022, is more than 1,000 times less potent as an MAO inhibitor. Both drugs, however, have neuroprotective activity in neuronal cell cultures in response to various neurotoxins, and in vivo in response to global ischemia, neurotrauma, head injury, anoxia, etc., indicating that MAO inhibition is not a prerequisite for neuroprotection. Their neuroprotective effect has been demonstrated to be associated directly with the propargylamine moiety, which protects mitochondrial viability and MTPp by activating Bcl‐2 and protein kinase C (PKC) and by downregulating the proapoptotic FAS and Bax protein families. Rasagiline and its derivatives also process amyloid precursor protein (APP) to the neuroprotective, neurotrophic, soluble APP α (sAPPα) by PKC‐ and MAP kinase‐dependent activation of α‐secretase. The identification of the propargylamine moiety as the neuroprotective component of rasagiline has led us to development of novel bifunctional anti‐Alzheimer drugs (ladostigil) possessing cholinesterase and brain‐selective MAO inhibitory activity and a similar neuroprotective mechanism of action. © 2004 Wiley‐Liss, Inc." @default.
• W2018792227 created "2016-06-24" @default.
• W2018792227 creator A5005030965 @default.
• W2018792227 creator A5012715564 @default.
• W2018792227 creator A5013702091 @default.
• W2018792227 creator A5048608152 @default.
• W2018792227 creator A5053858269 @default.
• W2018792227 creator A5055016023 @default.
• W2018792227 creator A5082642183 @default.
• W2018792227 date "2004-11-30" @default.
• W2018792227 modified "2023-09-26" @default.
• W2018792227 title "Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition" @default.
• W2018792227 cites W1486333767 @default.
• W2018792227 cites W1526193826 @default.
• W2018792227 cites W1537998114 @default.
• W2018792227 cites W1540436551 @default.
• W2018792227 cites W1551782890 @default.
• W2018792227 cites W1563482732 @default.
• W2018792227 cites W1829764364 @default.
• W2018792227 cites W1963897463 @default.
• W2018792227 cites W1964617786 @default.
• W2018792227 cites W1966513873 @default.
• W2018792227 cites W1966809742 @default.
• W2018792227 cites W1969150166 @default.
• W2018792227 cites W1971867070 @default.
• W2018792227 cites W1972717420 @default.
• W2018792227 cites W1976020912 @default.
• W2018792227 cites W1976062660 @default.
• W2018792227 cites W1979205386 @default.
• W2018792227 cites W1979240613 @default.
• W2018792227 cites W1979297739 @default.
• W2018792227 cites W1979710386 @default.
• W2018792227 cites W1981657815 @default.
• W2018792227 cites W1982811047 @default.
• W2018792227 cites W1988791308 @default.
• W2018792227 cites W1990519579 @default.
• W2018792227 cites W1990543766 @default.
• W2018792227 cites W1993282564 @default.
• W2018792227 cites W1993964261 @default.
• W2018792227 cites W1995410280 @default.
• W2018792227 cites W2001298537 @default.
• W2018792227 cites W2004436319 @default.
• W2018792227 cites W2006927641 @default.
• W2018792227 cites W2016833889 @default.
• W2018792227 cites W2017857028 @default.
• W2018792227 cites W2018114590 @default.
• W2018792227 cites W2026547060 @default.
• W2018792227 cites W2031786316 @default.
• W2018792227 cites W2031843850 @default.
• W2018792227 cites W2032770280 @default.
• W2018792227 cites W2034550136 @default.
• W2018792227 cites W2040506871 @default.
• W2018792227 cites W2042571235 @default.
• W2018792227 cites W2042584010 @default.
• W2018792227 cites W2046536863 @default.
• W2018792227 cites W2054136294 @default.
• W2018792227 cites W2057695809 @default.
• W2018792227 cites W2058340726 @default.
• W2018792227 cites W2062014268 @default.
• W2018792227 cites W2063488024 @default.
• W2018792227 cites W2063849763 @default.
• W2018792227 cites W2064247543 @default.
• W2018792227 cites W2071104796 @default.
• W2018792227 cites W2082953267 @default.
• W2018792227 cites W2083403240 @default.
• W2018792227 cites W2086365629 @default.
• W2018792227 cites W2087877138 @default.
• W2018792227 cites W2088142719 @default.
• W2018792227 cites W2088889614 @default.
• W2018792227 cites W2091558615 @default.
• W2018792227 cites W2091818830 @default.
• W2018792227 cites W2104145753 @default.
• W2018792227 cites W2107095942 @default.
• W2018792227 cites W2107462240 @default.
• W2018792227 cites W2123037265 @default.
• W2018792227 cites W2134673151 @default.
• W2018792227 cites W2134979684 @default.
• W2018792227 cites W2138979753 @default.
• W2018792227 cites W2139209618 @default.
• W2018792227 cites W2145879504 @default.
• W2018792227 cites W2156031498 @default.
• W2018792227 cites W2302113434 @default.
• W2018792227 cites W2394713914 @default.
• W2018792227 cites W2595176684 @default.
• W2018792227 cites W2786305788 @default.
• W2018792227 doi "https://doi.org/10.1002/jnr.20350" @default.
• W2018792227 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15573406" @default.
• W2018792227 hasPublicationYear "2004" @default.
• W2018792227 type Work @default.
• W2018792227 sameAs 2018792227 @default.
• W2018792227 citedByCount "152" @default.
• W2018792227 countsByYear W20187922272012 @default.
• W2018792227 countsByYear W20187922272013 @default.
• W2018792227 countsByYear W20187922272014 @default.
• W2018792227 countsByYear W20187922272015 @default.
• W2018792227 countsByYear W20187922272016 @default.
• W2018792227 countsByYear W20187922272017 @default.
• W2018792227 countsByYear W20187922272018 @default.

• next